D
Twist Bioscience Corporation
TWST
$39.96
$0.842.15%
D
Sell
8/14/2023Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D- from E+ on 8/14/2023 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 47.14% from -$44.29M to -$23.41M, EBIT increased 22.51% from -$62.83M to -$48.69M, and total revenue increased 5.92% from $60.18M to $63.74M.
Twist Bioscience Corporation (TWST) was upgraded to D- from E+ on 8/14/2023 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 47.14% from -$44.29M to -$23.41M, EBIT increased 22.51% from -$62.83M to -$48.69M, and total revenue increased 5.92% from $60.18M to $63.74M.
E
Sell
5/11/2023Downgrade
Twist Bioscience Corporation (TWST) was downgraded to E+ from D- on 5/11/2023 due to a decline in the volatility index, total return index and growth index.
Twist Bioscience Corporation (TWST) was downgraded to E+ from D- on 5/11/2023 due to a decline in the volatility index, total return index and growth index.
D
Sell
3/14/2023Downgrade
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and valuation index.
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and valuation index.
D
Sell
2/8/2023Downgrade
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the total return index and solvency index. The quick ratio declined from 6.01 to 5.76.
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the total return index and solvency index. The quick ratio declined from 6.01 to 5.76.
D
Sell
5/31/2022Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 05/31/2022.
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 05/31/2022.
D
Sell
5/13/2022Downgrade
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 5/13/2022 due to a decline in the growth index and volatility index. Earnings per share declined from -$0.9129 to -$1.1346, and EBIT declined 13.7% from -$58.77M to -$66.82M.
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 5/13/2022 due to a decline in the growth index and volatility index. Earnings per share declined from -$0.9129 to -$1.1346, and EBIT declined 13.7% from -$58.77M to -$66.82M.
D
Sell
5/5/2022Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index, volatility index and growth index. EBIT declined 39.15% from -$42.23M to -$58.77M, operating cash flow declined 34.05% from -$34.8M to -$46.65M, and earnings per share declined from -$0.8357 to -$0.9129.
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index, volatility index and growth index. EBIT declined 39.15% from -$42.23M to -$58.77M, operating cash flow declined 34.05% from -$34.8M to -$46.65M, and earnings per share declined from -$0.8357 to -$0.9129.
D
Sell
11/23/2021Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 11/23/2021 due to a noticeable increase in the total return index.
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 11/23/2021 due to a noticeable increase in the total return index.
D
Sell
11/8/2021Downgrade
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index, solvency index and growth index. The quick ratio declined from 14.41 to 9.99, operating cash flow declined 13.89% from -$24.55M to -$27.96M, and EBIT declined 5.86% from -$38M to -$40.23M.
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index, solvency index and growth index. The quick ratio declined from 14.41 to 9.99, operating cash flow declined 13.89% from -$24.55M to -$27.96M, and EBIT declined 5.86% from -$38M to -$40.23M.
D
Sell
3/8/2021Downgrade
Twist Bioscience Corporation (TWST) was downgraded to D from D+ on 3/8/2021 due to a significant decline in the total return index, growth index and volatility index. EBIT declined 36.83% from -$23.97M to -$32.79M, earnings per share declined from -$0.5431 to -$0.7152, and total revenue declined 13.17% from $32.43M to $28.16M.
Twist Bioscience Corporation (TWST) was downgraded to D from D+ on 3/8/2021 due to a significant decline in the total return index, growth index and volatility index. EBIT declined 36.83% from -$23.97M to -$32.79M, earnings per share declined from -$0.5431 to -$0.7152, and total revenue declined 13.17% from $32.43M to $28.16M.
D
Sell
1/29/2021Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D+ from D on 1/29/2021 due to a significant increase in the total return index, solvency index and growth index. Total revenue increased 52.93% from $21.21M to $32.43M, earnings per share increased from -$0.6742 to -$0.5431, and EBIT increased 15% from -$28.2M to -$23.97M.
Twist Bioscience Corporation (TWST) was upgraded to D+ from D on 1/29/2021 due to a significant increase in the total return index, solvency index and growth index. Total revenue increased 52.93% from $21.21M to $32.43M, earnings per share increased from -$0.6742 to -$0.5431, and EBIT increased 15% from -$28.2M to -$23.97M.
D
Sell
5/1/2020Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 5/1/2020 due to a large increase in the total return index and growth index. Total revenue increased 9.07% from $15.74M to $17.16M.
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 5/1/2020 due to a large increase in the total return index and growth index. Total revenue increased 9.07% from $15.74M to $17.16M.
D
Sell
12/17/2019Downgrade
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 12/17/2019 due to a decline in the volatility index, total return index and growth index. EBIT declined 12.26% from -$28.12M to -$31.57M, operating cash flow declined 5.78% from -$22.08M to -$23.36M, and earnings per share declined from -$0.9216 to -$0.9573.
Twist Bioscience Corporation (TWST) was downgraded to D- from D on 12/17/2019 due to a decline in the volatility index, total return index and growth index. EBIT declined 12.26% from -$28.12M to -$31.57M, operating cash flow declined 5.78% from -$22.08M to -$23.36M, and earnings per share declined from -$0.9216 to -$0.9573.
D
Sell
7/22/2019Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 7/22/2019 due to an increase in the total return index.
Twist Bioscience Corporation (TWST) was upgraded to D from D- on 7/22/2019 due to an increase in the total return index.
D
Sell
7/1/2019Upgraded
Twist Bioscience Corporation (TWST) was upgraded to D- from E+ on 7/1/2019 due to an increase in the total return index.
Twist Bioscience Corporation (TWST) was upgraded to D- from E+ on 7/1/2019 due to an increase in the total return index.
E
Sell
4/1/2019Upgraded
Twist Bioscience Corporation (TWST) was upgraded to E+ from E on 4/1/2019 due to a significant increase in the solvency index, total return index and growth index. Earnings per share increased from -$6.5704 to -$1.1799, the quick ratio increased from 4.65 to 7.22, and total revenue increased 36.7% from $8.41M to $11.49M.
Twist Bioscience Corporation (TWST) was upgraded to E+ from E on 4/1/2019 due to a significant increase in the solvency index, total return index and growth index. Earnings per share increased from -$6.5704 to -$1.1799, the quick ratio increased from 4.65 to 7.22, and total revenue increased 36.7% from $8.41M to $11.49M.
E
Sell
1/29/2019None
Twist Bioscience Corporation (TWST) was downgraded to E from U on 01/29/2019.
Twist Bioscience Corporation (TWST) was downgraded to E from U on 01/29/2019.
NASDAQ
03/14/2025 4:00PM Eastern
Quotes delayed
